» Articles » PMID: 17607348

Genomics and the Evolution, Pathogenesis, and Diagnosis of Tuberculosis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2007 Jul 4
PMID 17607348
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculosis kills nearly 2 million people annually, and current approaches to tuberculosis control are expensive, have limited efficacy, and are vulnerable to being overcome by extensively drug-resistant strains of Mycobacterium tuberculosis. Determination of the genome sequence of M. tuberculosis has revolutionized tuberculosis research, contributed to major advances in the understanding of the evolution and pathogenesis of M. tuberculosis, and facilitated development of new diagnostic tests with increased specificity for tuberculosis. In this review, we describe some of the major progress in tuberculosis research that has resulted from knowledge of the genome sequence and note some of the problems that remain unsolved.

Citing Articles

Virulence of Mycobacterium intracellulare clinical strains in a mouse model of lung infection - role of neutrophilic inflammation in disease severity.

Tateishi Y, Ozeki Y, Nishiyama A, Miki M, Maekura R, Kida H BMC Microbiol. 2023; 23(1):94.

PMID: 37009882 PMC: 10069106. DOI: 10.1186/s12866-023-02831-y.


Inhibition of the Niemann-Pick C1 protein is a conserved feature of multiple strains of pathogenic mycobacteria.

Weng Y, Shepherd D, Liu Y, Krishnan N, Robertson B, Platt N Nat Commun. 2022; 13(1):5320.

PMID: 36085278 PMC: 9463166. DOI: 10.1038/s41467-022-32553-0.


A combined application of molecular docking technology and indirect ELISA for the serodiagnosis of bovine tuberculosis.

Song S, Zhang Q, Yang H, Guo J, Xu M, Yang N J Vet Sci. 2022; 23(3):e50.

PMID: 35618322 PMC: 9149502. DOI: 10.4142/jvs.21270.


Interleukin 8 and Pentaxin (C-Reactive Protein) as Potential New Biomarkers of Bovine Tuberculosis.

Gao X, Guo X, Li M, Jia H, Lin W, Fang L J Clin Microbiol. 2019; 57(10).

PMID: 31340991 PMC: 6760949. DOI: 10.1128/JCM.00274-19.


Genetic Variation/Evolution and Differential Host Responses Resulting from In-Patient Adaptation of .

Kannan N, Lai Y, Haug M, Lilleness M, Bakke S, Marstad A Infect Immun. 2019; 87(4).

PMID: 30642899 PMC: 6434124. DOI: 10.1128/IAI.00323-18.


References
1.
Gagneux S, Long C, Small P, Van T, Schoolnik G, Bohannan B . The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science. 2006; 312(5782):1944-6. DOI: 10.1126/science.1124410. View

2.
Johnson P, Stuart R, Grayson M, Olden D, Clancy A, Ravn P . Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol. 1999; 6(6):934-7. PMC: 95801. DOI: 10.1128/CDLI.6.6.934-937.1999. View

3.
Banaiee N, Kincaid E, Buchwald U, Jacobs Jr W, Ernst J . Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol. 2006; 176(5):3019-27. DOI: 10.4049/jimmunol.176.5.3019. View

4.
Stanley S, Johndrow J, Manzanillo P, Cox J . The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J Immunol. 2007; 178(5):3143-52. DOI: 10.4049/jimmunol.178.5.3143. View

5.
Ramachandran S, Deshpande O, Roseman C, Rosenberg N, Feldman M, Cavalli-Sforza L . Support from the relationship of genetic and geographic distance in human populations for a serial founder effect originating in Africa. Proc Natl Acad Sci U S A. 2005; 102(44):15942-7. PMC: 1276087. DOI: 10.1073/pnas.0507611102. View